BioProcess International is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Ms. Qinghua Zhao (Jenny) is currently associate director leading process development at Salubris Biotherapeutics, Inc., which is an innovation-focused biotech with pioneering research and development programs. Qinghua Zhao leads a dedicated team on clone selection, upstream/downstream process development for the discovery and global development of novel and biologic therapeutics. Prior to the current responsibility, Ms. Zhao was a leading Scientist of Upstream Development & Operations at Teva Pharmaceutical Inc. She was responsible for later stage clinical antibody product process development, tech-transfer and CMO manufacturing on TEV-48125, treating Migraine. She brings comprehensive perspective with more than 20-year experience at Teva, Wyeth, Amplimmune, Humane Genome Science and GenVec in biopharmaceutical process and product development, manufacturing operations and quality assurance. Ms.Zhao earned her Master degree in Biochemical Engineering from University of Waterloo, Canada.